This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Randomized, Open-label, Phase 3 Trial of A+AVD V...
Clinical trial

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Read time: 1 mins
Last updated:22nd Nov 2012
Modified progression free survival (mPFS) per independent review facility (IRF)
Category Value
Study start date 2012-11-22

View full details